Genética, Fisiología y Microbiología
Département
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (19)
2024
2023
-
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Blood, Vol. 142, Núm. 20, pp. 1752-1756
-
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
British Journal of Haematology
-
Mitigation of peanut allergenic reactivity by combined processing: Pressured heating and enzymatic hydrolysis
Innovative Food Science and Emerging Technologies, Vol. 86
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility
Science Advances, Vol. 8, Núm. 44
2021
-
PD-L1 expression in peripheral T-cell lymphomas is not related to either PD-L1 gene amplification or rearrangements
Leukemia and Lymphoma, Vol. 62, Núm. 7, pp. 1648-1656
2018
-
A comprehensive study of calcific aortic stenosis: From rabbit to human samples
DMM Disease Models and Mechanisms, Vol. 11, Núm. 6
2017
-
Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer
Oncotarget, Vol. 8, Núm. 25, pp. 40169-40180
2016
-
C-Jun N-terminal kinase inactivation by mitogen-activated protein kinase phosphatase 1 determines resistance to taxanes and anthracyclines in breast cancer
Molecular Cancer Therapeutics, Vol. 15, Núm. 11, pp. 2780-2790
2015
-
Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer
Clinical Cancer Research, Vol. 21, Núm. 2, pp. 347-356
-
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
Oncotarget, Vol. 6, Núm. 6, pp. 4299-4314
-
Pyrosequencing-based assays for rapid detection of HER2 and HER3 mutations in clinical samples uncover an E332E mutation affecting HER3 in retroperitoneal leiomyosarcoma
International Journal of Molecular Sciences, Vol. 16, Núm. 8, pp. 19447-19457
2014
-
Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer
Oncotarget, Vol. 5, Núm. 1, pp. 196-210
-
Deregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasis
Journal of Surgical Oncology
-
Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 9, pp. 1823-1829
-
PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential
Molecular Cancer Therapeutics, Vol. 13, Núm. 4, pp. 938-947
-
Re: Role of oncogenic K-ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling
Journal of the National Cancer Institute